Tag Archives: Sandy Draper

SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)

SunTrust Robinson analyst Sandy Draper maintained a Buy rating on Health Catalyst (HCAT – Research Report) today and set a price target of $30.00. The company’s shares closed last Wednesday at $25.10. According to TipRanks.com, Draper is a 5-star analyst

SunTrust Robinson Reaffirms Their Buy Rating on Health Catalyst (HCAT)

In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Health Catalyst (HCAT – Research Report), with a price target of $35.00. The company’s shares closed last Monday at $25.69. According to TipRanks.com, Draper is

SunTrust Robinson Reaffirms Their Buy Rating on Healthequity (HQY)

In a report released today, Sandy Draper from SunTrust Robinson maintained a Buy rating on Healthequity (HQY – Research Report), with a price target of $55.00. The company’s shares closed last Monday at $41.29, close to its 52-week low of

Analysts Conflicted on These Technology Names: Allscripts (NASDAQ: MDRX), Guidewire (NYSE: GWRE) and Splunk (NASDAQ: SPLK)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Allscripts (MDRX – Research Report), Guidewire (GWRE – Research Report) and Splunk (SPLK – Research Report). Allscripts (MDRX) In a report released today,

Teladoc (TDOC) Receives a Hold from SunTrust Robinson

In a report released today, Sandy Draper from SunTrust Robinson reiterated a Hold rating on Teladoc (TDOC – Research Report), with a price target of $80.00. The company’s shares closed last Monday at $83.74, close to its 52-week high of

SunTrust Robinson Believes Charles River Labs (NYSE: CRL) Still Has Room to Grow

In a report released today, Sandy Draper from SunTrust Robinson reiterated a Buy rating on Charles River Labs (CRL – Research Report), with a price target of $150. The company’s shares closed yesterday at $136.23, close to its 52-week high